Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The immune cell membranes and local tissue environment represent a complex biological compartment rather than a single molecular target (Nature Reviews Cancer, 2021). This environment includes the lipid bilayers of various immune cells, such as T cells and macrophages, as well as the surrounding extracellular matrix (ECM), signaling molecules, and metabolic conditions like pH and oxygen levels (Journal of Cell Science, 2019). In many diseases, particularly cancer, this environment is altered to create an immunosuppressive niche that prevents effective immune clearance (NIH, National Cancer Institute). The local tissue environment, often referred to as the tumor microenvironment (TME) in oncology, acts as a physical and biochemical barrier to therapy. Therapeutic interventions often focus on modulating this environment—either by blocking inhibitory receptors on the cell membranes or by altering the physical and chemical properties of the local tissue—to restore normal immune function and improve drug penetration (PubMed, PMC6753017). For example, checkpoint inhibitors target proteins on the immune cell membrane to re-activate T cells within this milieu. Additionally, enzymes like hyaluronidase are used to degrade components of the local tissue environment to facilitate the spread of co-injected drugs. Understanding the interplay between the cellular membrane and the surrounding environment is crucial for developing next-generation immunotherapies and delivery systems.
Modulation of the local immune milieu through receptor-ligand blockade on cell membranes or enzymatic degradation of extracellular matrix components to enhance immune infiltration and drug delivery.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune cell membranes and local tissue environment.